Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 421 for “"Prodrugs"”.

  1. Delivery of phosphonoformate prodrugs

    … to improve transport properties are unsuitable prodrugs due to their rapid and complicated hydrolysis, involving competitive P-O and P-C bond cleavage. Diesters, though hydrolytically stable, are considered too polar to passively diffuse into the CNS. Hydrophilic drugs mimicking endogenous …

    aston Download PDF for Delivery of phosphonoformate prodrugs (opens in a new tab)

  2. Prodrugs of antiviral phosphonates

    … the transport properties of these molecules, prodrugs were synthesised and their stabilities and reconversion to the parent compound subsequently investigated by the techniques of 31P nuclear magnetic resonance spectroscopy and high performance liquid Chromatography. A series of 4-substituted …

    aston Download PDF for Prodrugs of antiviral phosphonates (opens in a new tab)

  3. PRODRUGS OF ENONES AS CANDIDATE ANTICANCER AGENTS

    … Mannich bases. (ii) Oximes of Mannich bases as prodrugs were contemplated with a view to attain selective release of the ketones in the tumourous tissue. (iii) Benzoates as pro-prodrugs were proposed since oximes have a polar hydroxy group which may impede passage via membranes and also in the …

    sask Repository record for PRODRUGS OF ENONES AS CANDIDATE ANTICANCER AGENTS (opens in a new tab)

  4. Pt(IV) anticancer prodrugs and liposomal encapsulation

    … photoactivatable platinum based anticancer prodrugs. The use of liposomes as a method of drug encapsulation for a known platinum complex is also explored. Finally, the synthesis of a microbubble-liposome conjugated system and the sonoluminescence effect of microbubbles are assessed. Chapter …

    oxford Repository record for Pt(IV) anticancer prodrugs and liposomal encapsulation (opens in a new tab)

  5. Hypoxia-selective antitumor prodrugs and fluorescent probes

    Hypoxia-selective antitumor prodrugs utilize the unique feature of most tumors -- hypoxia (low oxygen concentration), for therapeutic purpose and are widely studied in preclinical and clinical stages. Tirapazamine (TPZ, 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide) is a hypoxiaselective cytotoxin …

    missouri Repository record for Hypoxia-selective antitumor prodrugs and fluorescent probes (opens in a new tab)

  6. Characterization of photoactivatable Prodrugs of Kinase Inhibitors

    … and characterization of novel photoactivatable prodrugs of several approved small molecule kinase inhibitors. Photoremovable protecting groups were therefore covalently bound to key pharmacophore moieties of active kinase inhibitors. The implementation of a protecting group distinctly diminished …

    cau-kiel Repository record for Characterization of photoactivatable Prodrugs of Kinase Inhibitors (opens in a new tab)

  7. Evaluation of Antibiotic Release from Polymeric Prodrugs

    … infections, we have designed synthetic polymeric prodrugs with cleavable linkers bearing an antibiotic drug. Previously, in vitro experiments using percent drug release to characterize the release kinetics of the prodrugs have been performed. However, acid and base hydrolysis have been used to …

    washington Repository record for Evaluation of Antibiotic Release from Polymeric Prodrugs (opens in a new tab)

  8. Polymeric Prodrugs for Infectious Disease and Immune Therapies

    … body of work, we explore the adoption of polymer prodrugs (“drugamers”) to facilitate the delivery and controlled release of small molecule drugs to multiple important therapeutic settings. First, we explain why drugamers synthesized by Reversible Addition Fragmentation-chain Transfer (RAFT) are …

    washington Repository record for Polymeric Prodrugs for Infectious Disease and Immune Therapies (opens in a new tab)

  9. Glycan polymeric prodrugs against pulmonary intracellular alveolar infections

    … multivalent glycopolymer prodrug systems. Prodrugs are inactive forms of the drug, but when administered undergo hydrolysis to release the pharmacologically active drug. We hypothesized that engineering mannose glycopolymer prodrugs to target the macrophage mannose receptor on alveolar …

    washington Repository record for Glycan polymeric prodrugs against pulmonary intracellular alveolar infections (opens in a new tab)

  10. Pharmacokinetic studies of fluphenazine and four ester prodrugs

    … parent compound FLU after administration of the prodrugs in oil based injections. It was determined that the sesame oil/buffer partition coefficients (PC) decreased as the homogenous series of the ester chain length was increased, the effect of the chain length of the prodrug on the release rate …

    sask Repository record for Pharmacokinetic studies of fluphenazine and four ester prodrugs (opens in a new tab)

  11. Photoactivable prodrugs based on oxygen and nitrogen heterocycles

    … properties while retaining therapeutic activity. Prodrugs can be converted in vivo into the active drug, enzymatically or non-enzymatically, to exert a therapeutic effect. Also, there is a demand for spatial and temporal controlled drug delivery methods, which enable on demand release of …

    minho-thes Repository record for Photoactivable prodrugs based on oxygen and nitrogen heterocycles (opens in a new tab)

  12. Design of Safer Prodrugs Powered by Machine Learning

    <p>Prodrugs are easily deployable chemical entities with beneficial pharmacokinetic properties that harness biotransformations to generate active pharmaceutical ingredients (APIs) in situ. However, the rational design of prodrugs is challenging as it requires careful crafting of release mechanisms …

    duke Repository record for Design of Safer Prodrugs Powered by Machine Learning (opens in a new tab)

  13. Bioreductive prodrugs for the targeting of epigenetic enzymes

    … by the observed side effects. In this project, prodrugs for a site-specific drug release were developed that are activated by the NADH-dependent bacterial nitroreductase NfsB (NTR) and subsequently release the LSD1 or HDAC inhibitor. The NTR, which is introduced into the cancer cell by …

    freiburg-diss Repository record for Bioreductive prodrugs for the targeting of epigenetic enzymes (opens in a new tab)

  14. Neue Prodrugs von Diamidinen zur Therapie protozoischer Erkrankungen

    … dieser Arbeit wurden unterschiedliche doppelte Prodrugs von Diminazen und Pentamidin entwickelt, um deren chemischen und pharmakokinetischen Eigenschaften zu verbessern. Zur Erreichung dieses Ziels wurden mehrere Derivate der Diamidine synthetisiert, in vitro auf ihre Bioaktivierung hin …

    cau-kiel Repository record for Neue Prodrugs von Diamidinen zur Therapie protozoischer Erkrankungen (opens in a new tab)

  15. Aktivierung eines photoresponsiven Kinaseinhibitor-Prodrugs durch Tscherenkow-Strahlung

    … Charakterisierung dieses photoresponsiven Prodrugs wurde die Abspaltung der Schutzgruppe in Zusammenhang mit der von Radionukliden ausgesendeten Tscherenkow-Strahlung untersucht.

    cau-kiel Repository record for Aktivierung eines photoresponsiven Kinaseinhibitor-Prodrugs durch Tscherenkow-Strahlung (opens in a new tab)

  16. Development of Novel Polymeric Prodrugs for Antimicrobial Applications

    … the development of polymeric and dendritic prodrugs that remain inactive under physiological conditions and are selectively activated at infection sites through external, biological, or chemical stimuli. The thesis begins with a systematic investigation into structure-activity relationships …

    unsw Repository record for Development of Novel Polymeric Prodrugs for Antimicrobial Applications (opens in a new tab)

  17. In vitro stability of cannabinergic prodrugs in plasma

    … This issue can be addressed by creating prodrugs of these compounds with enhanced bioavailability. This study evaluates the in vitro half lives of monofunctional and bifunctional esteratic prodrug structures of two CB2-targeted cannabinergic drugs. These prodrug formulations have one or …

    bu Repository record for In vitro stability of cannabinergic prodrugs in plasma (opens in a new tab)

  18. Self-Assembling Prodrugs: From Supramolecular Polymer to Supramolecular Medicine

    … Specifically, I will use self-assembling prodrugs (SAPDs) as examples, which are an emerging class of supramolecular medicines that are able to associate into well-defined therapeutic supramolecular polymers in aqueous environments with tunable physicochemical and biological properties. In …

    jhu Repository record for Self-Assembling Prodrugs: From Supramolecular Polymer to Supramolecular Medicine (opens in a new tab)

  19. INVESTIGATION OF ASYMMETRIC PLATINUM (IV) COMPLEXES AS ANTICANCER PRODRUGS

    … AND SEVERE SIDE-EFFECTS. PLATINUM(IV) ANTICANCER PRODRUGS CAN OVERCOME THESE LIMITATIONS BY RESISTING PREMATURE AQUATION AND BINDING TO ESSENTIAL PLASMA PROTEINS. CLASSICAL SYMMETRIC PLATINUM(IV) PRODRUG COMPLEXES ARE LIMITED IN THEIR SYNTHETIC UTILITY AS THEIR AXIAL LIGAND SITES FOR …

    nus Repository record for INVESTIGATION OF ASYMMETRIC PLATINUM (IV) COMPLEXES AS ANTICANCER PRODRUGS (opens in a new tab) Download file for INVESTIGATION OF ASYMMETRIC PLATINUM (IV) COMPLEXES AS ANTICANCER PRODRUGS (opens in a new tab)

Page 1 of 22